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 Organ transplantation is a method of treating diseases and restoring organ function that involves 
procuring an organ from a donor and transplanting it into a recipient. Due to the success and growth of 
this field of treatment, the is a large demand for available organs. However, there a vast difference 
between the number of available organs and patients waiting for an organ. In 2013, there were 121,272 
patients on the waitlist for an organ donation but only 28.954 organs were transplanted that year. In order 
to combat the discrepancy between those two numbers, the field of organ transplantation is turning to 
organ preservation. At first, static cold storage was used to lower the metabolic rate of the organs and thus 
preserve them. However, that technique still caused hypoxic damage to the organs. Thus the use of organ 
perfusion systems became more common for organ preservation. Even though there are several 
commercialized perfusion systems for tradition organs, there are no specialized systems for vascularized 
composite allografts (VCA). Unlike traditional solid organs, VCA are composed of multiple tissue types 
(i.e. skin, muscle, and bone). Examples of VCA are hand or face transplants. Even though these types of 
transplants are not considered live-saving, they can be can be considered as life-restoring.  
  Here we describe the design of a bioreactor system that is capable of maintaining the rat 
abdominal wall VCA. This type of model is chosen because abdominal wall transplants are the second 
most common type of VCA. The bioreactor system will store the abdominal wall in a safe and sterile 
environment while allowing for the perfusion of the tissue with a specialized organ solution 
simultaneously with electrical stimulation. This bioreactor system will contain various sensors, including 
pressure, oxygen, pH, and temperature, to monitor the viability of the abdominal wall throughout the 
perfusion. With this bioreactor, many more studies on the preservation of VCA can be performed, with 
the eventual goal of increasing the current gold standard’s maximum preservation time of 4-6 hours to 
eventually 72 hours.  
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CHAPTER 1: TRANSPLANTATION AND PRESERVATION 
1.1 Organ Transplants and Vascularized Composite Allografts (VCA) 
 Organ transplantation to treat diseases and restore organ function is not a new concept. 
Throughout history and even religious texts, there have been stories of organs or tissues being 
transplanted, but it was not until 1883 that Theodor Kocher successfully transplanted thyroid 
tissue from one patient into another [1]. His work with the thyroid transplants would lead to the 
growth of organ transplantation as an accepted method of treatment for organ failure. 
Throughout the years, there would be an increased number of organ transplant surgeries and new 
developments such as Alexis Carrel and Charles Guthrie’s first heart transplant in a dog model in 
1905 [1]. However, those transplants would eventually fail due to the recipient’s immune 
response and rejection of transplanted organ [2]. It would not be until 1954 that the first 
successful human kidney transplant was performed by Dr. Joseph Murray and John Merrill and 
1967 that the first successful human heart transplant would be completed by Dr. Christian 
Barnard [2, 3].  
 As the strategies for immunosuppression for organ transplants became better defined and 
the number of organ transplants began to rise, the number of available organs from organ donors 
would also rise as new legislation changed the definition of brain death, the timing and 
techniques of organ procurement from donors, and extended organ donor criteria. However, the 
number of patients waiting for organ transplants would increase at a much greater rate than the 
slowly growing number of available organs. This trend can be seen in Figure 1.1.  
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Figure 1.1 Trend for Organ Transplant Waiting List, Transplants, and Organ Donors [4] 
 Since there is an ever growing number of patients waiting for an organ donation, there is 
an increasing need to obtain more organs that are viable for transplantation. Even after an organ 
is procured from a donor, it is not always transplanted into a recipient. For example, about 20% 
of kidneys (totaling 3159) that were obtained for transplantation were discarded in 2015 [5]. 
Even though some of those organs may be discarded because they are physically unfit for 
donation, many become damaged during transport, or some organs are discarded because they 
cannot be matched to a suitable recipient within a certain time period [4]. After an organ is 
obtained from a donor, it is matched to a suitable recipient based on factors such as blood type, 
the physical characteristics of the organ, the patient’s medical condition, and even distance 
between the donated organ and recipient [6]. If a recipient is found, the organ is stored in a bag 
of chilled preservation solution over ice, which is the current gold standard for organ 
preservation, and transported to the recipient. During transport, the organ is cut off from any 
oxygen supply and suffers from ischemia – the deprivation of oxygen, and glucose supply to the 
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organ – which leads to degradation of the organ. Figure 1.2 lists the maximum allowable cold 
ischemia time for various organs. During that period of maximum allowable ischemia time, the 
organ needs to be matched to an appropriate recipient, transported to that recipient, and 
transplanted into the recipient.  
 
Figure 1.2 Common Maximum Ischemia Times for Various Organs [6] 
 With the success and growth of the solid organ transplantation field, the number of 
Vascularized Composite Allotransplantations or Vascularized Composite Allografts (VCA) is 
also increasing. VCA are composed of multiple tissue types such as skin, muscle, and bone and 
are used to replace tissue defects that cannot be reconstructed, such as those lost due to trauma or 
accidents [7]. Examples of these can be seen in face or limb transplantations [8]. Even though 
these transplants are not considered lifesaving surgeries, they can be seen as “life-restoring” 
since they allow for restoration of both function and aesthetics when compared to autologous 
tissue reconstructions and prosthetics [8]. Due to their composite nature, VCA require a wider 
range of immunosuppressants due to the immunogenicity of skin and have limited preservation 
times of 4-6 hours due to the skeletal muscle component [7]. In the United States, traumatic 
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amputation is the second leading cause of limb loss and over 100 limb transplants have been 
performed worldwide since 1999 [9]. In 2013, the United States Department of Health and 
Human Services (HSS) stated that VCA are designated as organs and they will be regulated by 
the Organ Procurement and Transplant Network (OPTN) together with the United Network for 
Organ Sharing (UNOS) [10]. Like the other organs of conventional organ transplants, VCA also 
suffer from ischemia during transportation times and methods of combating the ischemia is being 
researched.  
1.2 Organ Preservation 
 The goal of organ preservation is to maintain the viability and function of the organ 
outside of the body. Without the rest of the body to provide an adequate supply of oxygen, 
glucose, other nutrients, and metabolic waste removal through blood flow, the body undergoes 
ischemia. During ischemia, the cells switch from producing ATP via oxidative metabolism to 
anaerobic metabolism, which is less efficient [11]. The use of anaerobic metabolism leads to the 
buildup of metabolites such as lactic acid, which lowers the cellular pH and other changes, which 
affects the function of enzymes and both the mitochondrial and cellular membrane pumps [11]. 
Ischemia and anaerobic metabolism affects the electrolyte concentration, which causes a shift in 
the oncotic pressure, leading to cellular swelling, rupture, and cellular apoptosis [11]. Reactive 
oxygen species (ROS), such as NADPH oxidase (NOX) are also produced during ischemia and 
anaerobic metabolism, which affects the function of the mitochondria and can lead to a 
reciprocal production of more ROS [11].  
 Ischemia-reperfusion injury is an autoimmune event that occurs due to a restoration of 
blood flow after a period of ischemia [12]. With the restoration of blood flow, there is also a 
restoration of oxygen and glucose supply, which allows the cells to switch back to oxidative 
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metabolism [11]. But this leads to a large increase in ROS production since the mitochondria’s 
mechanisms for oxidative metabolism are damaged during ischemia [11]. The addition of ROS 
leads to the disruption of the mitochondrial membrane and the release of mitochondria-specific 
proteins into the cytosol, which triggers apoptosis and the activation of the innate immune 
system [11]. Even though the immune system normally is needed for regeneration and healing, 
during ischemic reperfusion injury (IRI), both injured and dead cells release molecules that cause 
them to be attacked by neutrophils [11]. This can lead to a cascade of events and may ultimately 
result in organ failure [12]. Nitric oxide (NO) levels are also affected by the buildup of ROS, 
which leads to deactivation of adhesion molecules on the surfaces of cells, leading to the 
transmigration of immune cells to other parts of the body [11].  
 In addition to causing organ failure, ischemia-reperfusion injury in transplanted tissues 
and organs can also lead to acute rejection or affect the long-term recipient’s acceptance of the 
transplant [8]. In 2010, Shimizu et al found that transplants that underwent longer periods of 
ischemia resulted in a more severe rejection of the tissue [13]. Thus, the goal of organ 
preservation is to limit the period of ischemia time in order to reduce the effects of ischemia-
reperfusion injury. 
 There are two overarching strategies for organ preservation: 1. Suppression of the organ’s 
metabolism using hypothermic conditions and 2. Replacing the physiological environment 
through normothermic environments and biophysical stimulation.  
 The current gold standard of organ preservation is to store the organ within a chilled and 
specialized preservation solution during transport, which is known as static cold storage. Static 
cold storage lowers the temperature of the organ to about 0-4C to lower the metabolic demand 
of the organ during transport. For every 10C in temperature, there is a 50% decrease in 
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metabolic rate, eventually resulting in a metabolic rate of 10-12% of normal physiological levels 
at 4C [14]. Even though the metabolic demand is lower, organs undergoing static cold storage 
still suffer from oxidative stress, the production of ROS, and inflammation [15].  
 Specialized preservation solutions were developed to help combat the molecular changes 
in the organs. One of the first solutions to be developed was the EuroCollins solutions in the 
1980s. It is a solution that uses a high potassium ion concentration as an osmotic barrier and 
glucose [15]. Even though it was successfully used to preserve kidneys, hearts, livers, and lungs, 
the preservation times of those organs using this solution was also lowered [15]. Since the 
glucose was converted to lactate and resulted in acidosis, the solution was later modified to use 
sucrose or mannitol instead of glucose [15]. The University of Wisconsin (UW) solution was 
also developed in the 1980s and is used as the gold standard for liver grafts since [15]. It works 
by 1. Preventing edema, 2. Supplying the cells with adenosine, the precursor of ATP, and 3) 
Providing antioxidant defense while being able to be used with multiple types of tissues since its 
components are all metabolically inert [15]. Histidine-Tryptophan-Ketoglutarate (HTK) is 
another commonly used preservation that uses its histidine content to augment the osmotic effect 
of mannitol to prevent edema, tryptophan to stabilize cellular membranes and to prevent histidine 
from entering cells, and ketoglutarate as a substrate for anaerobic metabolism during perfusion 
[16]. 
 Even though static cold storage is able to lower the metabolic demands of the organs 
during preservation, there is still a metabolic demand for oxygen and glucose. The organs are 
submerged in preservation solutions that contain oxygen and other substrates for metabolism, yet 
the slow diffusion rate of oxygen and those substrates through the tissue prevents an adequate 
supply of oxygen and metabolic substrates into the deeper regions of the tissue. Thus, the field 
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has turned to machine perfusion of the organs to deliver the necessary nutrients throughout the 
rest of the organ.  
 The idea of perfusing organs outside of the body is not new: in 1812, the physiologist Le 
Gallois once wrote that “if one could substitute for the heart a kind of injection… of arterial 
blood, either naturally or artificially made, … one would succeed easily in maintaining alive 
indefinitely any part of the body whatsoever” [17]. In other words, he theorized that it is possible 
to preserve an organ outside of the body as long as the physiological environment of the organ 
can be mimicked.  
 Even though the concept of organ preservation via perfusion has been around for a while 
and there were a few rudimentary attempts at ex-vivo organ perfusion, it was not until 1935 
when an entire system was created for organ perfusion. In 1935, Alexis Carrel created a setup 
that was able to perfuse ovaries, adrenal glands, thyroid glands, spleens, hearts, or kidneys from 
a cat or fowl [18]. By pumping perfusate throughout the organ, Carrel et al were able to provide 
sufficient nutrient and oxygen delivery throughout the organs and extend their preservation 
times.  
 The dual approach to organ preservation through hypothermic machine perfusion (HMP) 
has been well studied and is traditionally more common compared to normothermic machine 
perfusion (NMP), which uses temperatures from 12-37C. For examples, kidneys have been 
successfully transplanted even after 24 hours of hypothermic machine perfusion [19]. Even 
though hypothermic preservation is capable of prolonging organ preservation times, 
normothermic preservation provides inherent advantages over hypothermic conditions. With 
hypothermic preservation, there will always be a maximum preservation time, hypothermia 
affects cell and organ function so it does not allow for viability and functional assessments of the 
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organ, and the organs will suffer from hypothermic preservation damage as they are being 
preserved for longer periods of time [19]. Since the organ donor criteria has expanded in order to 
meet the ever growing demand for organs, organs that would have been discarded before are now 
being used for transplantation. Those organs are often sensitive to hypothermia and are not able 
to survive the damage that hypothermic preservation causes [19]. By using normothermic 
preservation, it is theoretically possible to avoid the disadvantages of hypothermic preservation. 
It allows for the storage of organs in a metabolically active state by providing oxygen and 
nutrients without cooling. Normothermic preservation would also allow for the function and 
viability of organs to be assessed during preservation and can possibly recover organs that are 
considered “marginal” or injured [19].  
1.3 Perfusion Systems 
 The components of Alexis Carrel’s ex-vivo organ perfusion system are still commonly 
used in the contemporary perfusion systems. Their set up contained 1) a housing chamber to 
maintain a sterile environment for the organ, 2) a perfusate medium that would supply a 
sufficient amount of oxygen and nutrients to the organ, 3) a way to replenish the amount of 
oxygen in the perfusate, and 4) phenol red was also added to the perfusate as a non-invasive way 
to monitor the pH and thus the metabolic activity of the organ.  
 Even though they were able to perfuse various organs for a longer period of time, there 
were still various limitations with their system. For example, their system did not have a way to 
measure viability of the organ or its function besides using phenol red to give a relative 
measurement of pH changes. In their paper, the authors also describe  how the organs often had a 
large increase in weight and the authors credited that to tissue growth and generation from the 
perfusion [18]. However, many recent studies have shown that the weight gain is a byproduct of 
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edema, not tissue growth. Even though there are short-comings with Carrel’s 1935 perfusion 
system, many perfusion systems of today also incorporate similar components into their systems: 
a Housing System, Perfusate, a Perfusion Loop, and Non-Invasive Measurement Methods. 
 Housing systems provide a closed and sterile environment to protect the organ from 
bacterial infections and provide a reproducible way for the perfusion system to connect to the 
organ. They also maintain the hydration of the tissue or organ.  
 Perfusates are pumped throughout the organ to provide oxygen and other nutrients for 
metabolism. There are several specialized perfusates such as the previously mentioned 
EuroCollins and University of Wisconsin solutions. Each solution has its own unique additives in 
order to attenuate organ damage during perfusion. For example, several preservation solutions 
contain additives to control the osmolality of the solution to prevent swelling in the organ.  
 Perfusion Loops contain pumps and other devices for pressure-driven flow of the 
perfusate through the organ. Key elements of perfusion loops include a pump, oxygenator, 
perfusate reservoir, heat exchangers, tubing, and sensors. The pump drives the perfusate. The 
oxygenator replenishes the oxygen supply in the perfusate to promote aerobic metabolism in the 
organ. The reservoir stores excess perfusate to essentially provide a semi-batch process where 
the perfusate only needs to be replenished intermittently. Heat exchangers or temperature 
controllers are used to adjust the temperature of the perfusate as needed for either hypothermic or 
normothermic perfusion. The tubing connects the different components of the perfusion loop and 
houses the flow through sensors for measurement of various perfusate parameters such as 
pressure. In order to prevent pressure related damage to the organs, many perfusion systems 
operate at pressures that are lower than physiological levels (80-120 mmHg for humans) [20]. 
An example of these components can be seen in OrganOx’s metra normothermic liver perfusion 
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devices. It contains a perfusion pump that maintains the hepatic artery pressure between 60-75 
mmHg, an oxygenator that keeps the respective partial pressures of oxygen and carbon dioxide at 
12 kPa and 5 kPa respectively, and a heat exchanger to maintain the perfusate temperature at 
37C [21].  
 Non-invasive measurements allow for continuous and automatic measurements of the 
perfusate and the organ for monitoring of the organ’s functions and viability. Perfusion systems 
commonly include pressure, flow rate, temperature, pH, and oxygen sensors. Other sensors can 
include glucose and lactate sensors in order to monitor the metabolism of the organ. Perfusion 
systems that are specialized for a type of organ can include sensors that can monitor a specific 
function of that organ. For example, Transmedic’s Organ Care System for the Heart allows for 
the continuous monitoring of heart rate via an electrocardiogram while checking for any 
fibrillations of the heart during preservation and transport [22]. It also includes an electrode to 
measure the heart’s electrocardiogram ad R-wave to adjust the pump speed and thus pump stroke 
volume as needed to maintain a continuous flow in the system [22].  
 1.3.1 Solid Organs 
 Over the past couple of decades, several companies developed specialized systems for the 
perfusion and preservation of various organs. The following table lists commercially available 
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heart rate, blood temperature 
 Housing enables ultrasound 
assessment and blood sampling 
 Console is reusable, but perfusion 
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disposable/single use 
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 Hypothermic perfusion 
 Monitors: temperature, flow rate, 
vascular resistance, and pressure 
 System is reusable, perfusion kit is 
single use 




 Uses preservation solution 
 Temperature controllable 10-38C 
 Oxygenates solution 
 Outputs flow, temperature, and 
pressure readings 
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 Uses blood 
 Normothermic perfusion 
 Maintains oxygen in perfusion 
 Measures pO2, pCO2, pH, 
temperature, glucose, bile 
production 
 Console is reusable but has a sterile 
disposable portion for single use 





 Uses donor blood + solution mix 
 Normothermic Perfusion 34-37C 
 Maintains oxygen in perfusion 
 Measures lactate in perfusate and 
bile production for evaluation 
 Enables ultrasound assessment and 
blood sampling 
 Console is reusable, but perfusion 
set is one-time use 
 Large but transportable 
 
 1.3.2 Vascularized Composite Allografts  
 At the moment, there are not any commercially available perfusion systems for VCA 
perfusion and the current gold standard for preserving VCA involves static cold storage at 
around 0-4C. Thus, these types of transplantations need to be done within 4-6 hours of 
ischemia. There is a trend towards researching and developing methods and devices for 
extracorporeal VCA perfusion. Two notable groups are the Ozer and Kueckelhaus groups.  
 In 2016, Kueckelhaus et al developed a mobile system that is use for perfusing porcine 
limbs. Their system uses a peristaltic pump to perfuse cool and oxygenated Perfadex solution 
into a porcine forelimb for 12 hours while taking measurements such as pressure, oxygen, and 
temperature and taking samples of the perfusate for blood gas analysis. Even though their 
perfused limbs had a significant amount of weight gain compared to limbs stored in static cold 
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storage, they were able to electrically stimulate their limbs for a longer amount of time into the 
perfusion. Histological analysis of the perfused limbs does not show hypoxic damage to the cells 
while the cold storage limbs do [9]. In 2017, they again compared their perfusion system to static 
cold storage by replanting the limb onto the donor pig after 12 hours of perfusion or 4 hours of 
cold storage. After replantation, they monitored the pigs for 7 days. They found that the control 
animals (limbs preserved with cold storage) had higher levels of potassium and myoglobin in 
their blood, which suggests muscular tissue damage. They also found that the expression of 
Hypoxia-inducible factor 1-alpha (HIF-1α) and Hypoxia-inducible factor 1-beta (HIF-1β) in the 
perfused limbs were comparable to fresh muscle tissue, which suggests the limbs were 
adequately oxygenated. One of the four pigs in the control group (static cold storage) died of 
pulmonary complications, which is a consequence of ischemia-reperfusion injury, while all of 
the 3 pigs in the treatment group (perfusion) survived past the 7-day mark [39].  
 In 2015, the Ozer group created their own porcine limb perfusion set up that perfused 
warm (27-32C) autologous blood into the limbs instead of using a cool acellular solution like 
the Kueckelhaus group. After 12 hours of perfusion or 6 hours of static cold storage, the limbs 
were transplanted onto another pig host. They monitored the perfusion parameters such as 
temperature and pressure during perfusion, collected the perfusate for blood gas analysis, and 
checked for muscle contraction of muscle fiber bundles using a nerve stimulator. Even after 12 
hours of perfusion, they found that the muscle fibers were still able to contract [40]. In a 2016 
report, they used the same set up but perfused the porcine limbs for 24 hours instead of the 12 
hours in the previous year. Once again, they found that the perfusion group had better results 
than the cold storage group since the muscle fibers were able to contract upon electrical 
stimulation after 24 hours of perfusion, indicating the presence of healthy myocyte units [41]. In 
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2017, the group reported on a perfusion set up of a human forelimb from brain dead adult donors 
for 24 hours. After perfusion, they performed histology on the muscle fibers of the limbs and 
found that there were no signs of necrosis, degeneration, or inflammatory cell infiltration. Also, 
they were able to stimulate and obtain contraction from both dissected single muscle fibers and 
the whole limb against gravity. Their findings indicate that they were able to use near-
normothermic extracorporeal perfusion to preserve human VCA function for at least 24 hours 
[42]. 
 1.3.3 Limitations of Other Perfusion Systems 
 Even though all of the perfusion systems mentioned in the previous sections are 
theoretically able to extend the preservation times of their organs, there are no systems that are 
designed specifically for VCA. The commercialized perfusion systems are designed for their 
specific organs such as the heart or lungs while the perfusion systems of the Kueckelhaus and 
Ozer groups are relatively primitive. While those systems are able to pump perfusate throughout 
the organ, there are no specialized sensors for monitoring VCA biomarkers to measure the 
function and viability of the organ. In our proposed system for rat abdominal wall perfusion, we 
will include specialized sensors that will be able to monitor the status of the abdominal wall 
along with an electrical stimulation system with force sensors to monitor the functionality of the 
tissue. Figure 1.3 shows an artistic rendering of the proposed bioreactor system with the 
enclosed abdominal wall with an attached force sensor. Connected to the bioreactor is the flow 
through system with various flow through sensors and components such as the pump as well as 
the electrical stimulation system. 
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Figure 1.3 Artistic Representation of Multiparametric Bioreactor. In the center is the bioreactor housing with 
the embedded tissue graft, force sensor, and electrical stimulation system (Right). On the left is the perfusion 
circuit with the peristaltic pump, oxygenator, and various inline sensors. 
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CHAPTER 2: RAT ABDOMINAL WALL VCA MODEL 
2.1 The Rat Abdominal Wall 
 With over 40 surgeries completed as of 2015, the abdominal wall transplant is the second 
most common form of VCA transplant [43]. The animal model this project focuses on is the 
rodent abdominal wall VCA model, which was pioneered by the Brandacher lab [43]. The 
abdominal wall is composed of three layers of muscles: the transverse abdominis, internal 
oblique, and external oblique and consists of multiple types of tissues: skin, muscle, and 
subcutaneous fat [44]. It is needed for many mechanical functions such as generating motions 
such as twisting, lateral bending, and flexion as well as maintaining spinal column stability and 
intra-abdominal pressure [44].  
2.2 Harvesting and Perfusing the Abdominal Wall VCA 
 
Figure 2.1 Experimental Rat VCA Models. The top left image shows the area where the rat abdominal wall 
VCA will be harvested from while the top right image shows the rat forelimb VCA model. The bottom three 
images show an abdominal wall that has been harvested and was perfused with Evans Blue Dye at three 
different time points.  
 For this project, adult Lewis rats are used. The bottom three images of Figure 2.1  
demonstrates how the artery that the perfusion needle is connected to is connected to a majority 
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of the vessels in the tissue and how we are able to pump perfusate to a majority of the abdominal 
wall.  
 The rat is first anesthetized with 2.5% isoflurane and the area of interest is shaved and 
cleaned with alternating applications of betadine and 70% alcohol. Afterwards, the areas of 
interest are marked. Normally, the abdominal wall removed is approximately 4cm x 4cm in size. 
The abdominal wall consists of two halves that are separated by the linea alba. An image of the 
prepared rat can be seen in Figure 2.2.  
 
Figure 2.2 Anesthetized Rat with Shaved and Marked Abdomen. The areas of interest are marked with the 
black lines. The two halves of the abdominal wall are separated by the linea alba. Only one half is used at a 
time for perfusion or transplantation. 
 Next, an incision is made to expose the superficial epigastric and femoral vessels. The 
femoral artery is preserved during the surgery because it is used to perfuse the abdominal wall 
during surgery as well as for anastomosis during the transplantation surgery. The skin is then cut 
around the perimeter of marked area and the muscle layer is cut afterwards. During the process 
of cutting the muscle layers, the edges of the graft are cauterized to prevent excessive bleeding.  
 19 
 
Figure 2.3 The Abdomen with Cut Skin and Cauterized Edges. A shows the cut skin, exposed arteries, 
and linea alba while B shows the flipped graft with cauterized edges 
  
 Afterwards, the external iliac and femoral arteries are dissected and their branches are 
cauterized. The external ilia is then tied off and the vessels are cut. The blood is flushed out of 
the graft with 10 mL of heparinized saline (2.4% heparin + 97.6% lactated Ringer’s solution). 
The graft is then covered with wet gauze and prepared for either perfusion or the transplantation 
surgery if it will not be perfused for preservation. If the graft is to be used for perfusion, the 
cauterized edges are removed because preliminary perfusion experiments have found that there is 
an excessive amount of edema due to perfusion. Removal of the cauterized edges allow for the 
perfusate to leak out of the perfusate, reducing the amount of edema. Afterwards, it is transported 
into the bioreactor system and a flushing needle is inserted into the femoral artery. Figure 2.4 






Figure 2.4 The Harvested Abdominal Wall with Intact Vessels.  
2.3 Model for Transplantation 
 To prepare the graft for surgery, the recipient rat will be prepared with similar steps to the 
donor rat and the femoral vessels are dissected. Edges of the graft are then removed to reduce the 
size of the transplant and the edges are re-cauterized. The size of the transplant is reduced 
because larger grafts are unable to be perfused properly from the anastomosis process, leading to 
necrosis of the tissue. The surgery team discovered the limitation of inadequate perfusion can be 
achieved by using a smaller graft for transplant. Figure 2.5 shows a graft with the edges that are 





Figure 2.5 The Reduced Graft Sizes. Left: Intact graft with areas marked for removal. Right: The graft with 
the excess areas removed.  
 Next, the graft’s external iliac vessels are anastomosed to the recipient’s femoral muscles.  
The graft is then placed into the recipient and sutured in place. Later, the recipient rat is then 
given 0.8 mL of buprenorphine and antibiotics. Afterwards, the surgery site is covered with 
bandages and the rat is allowed to recover. It is then monitored for several days post-surgery. 
Figure 2.6 shows an abdominal wall transplant 5 days post-surgery.  
 
Figure 2.6 A Rat Abdominal Wall Transplant 5 Days Post-Surgery
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CHAPTER 3: BIOREACTOR HOUSING AND DESIGN 
3.1 Bioreactor Housing Design and Fabrication 
 The housing provides a sealed and thus safe and sterile environment for the rat VCA. In 
addition to the sealed environment, the tissue will be coated with a biocompatible electrode gel 
to 1) enable the conduction of stimulation across the tissue and 2) aid in keeping the tissue 
hydrated. Below in Figure 3.1 is an overall SolidWorks view of the proposed bioreactor system. 
It consists of five main pieces: a base, a left wall, a right wall, a back wall, and a top cover. Each 
of those pieces will be fabricated from clear polycarbonate, which is a light and durable plastic 
material that is easy to machine. Since it is clear, it will also allow for visualization of the inner 
space of the bioreactor once it is sealed. Each of those pieces will be held together with a 0/80 x 
¾ stainless steel screw. The respective length, width, and height of the bioreactor is 25, 14.6, and 
17cm. This allows for the force sensor to be enclosed within the system and for the required 
tubing, connectors, and perfusion needles to connect between the perfusion inlet and the vessels 
of the tissue.  
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Figure 3.1 Overall Bioreactor Design in Solidworks  
 
Figure 3.2 Top Down View of Bioreactor. The center red object represents the abdominal wall graft and 
above it is the force sensor. On both the left and right walls of the bioreactor, there is an inlet and outlet for 









 The bioreactor includes a platform that the tissue is secured to with two clamps and two 
sets of perfusion inlets and outlets, which allows for the perfusate to enter and leave the 
bioreactor. There are two sets of perfusion inlets and outlets because during the abdominal wall 
harvest surgery, only one half of the abdomen is harvested at a time, thus there are two possible 
orientations of the grafts and its vessels. This can be seen in Figure 2.2. On the left and right 
walls of the bioreactor, there are two metal brackets that allow for the electrical stimulation 
signal to conduct from the outside to the inside of the bioreactor. The force transducer, 
MLT1030/D by ADInstruments, is secured to the back wall via a screw. A thread is used to 
connect the tissue to the force sensor. These features can be seen in Figures 3.2 and 3.3.  
 
Figure 3.3 Inner Space of Bioreactor. The walls the bioreactor were hidden in order to help visualize the 










Figure 3.4 The MLT1030/D Force Transducer with the 5 Blades Fanned Out. 
 
Figure 3.5 The Method of Connecting the Tissue to Force Sensor [44]. Left: A picture of the set up with the 
flipped abdominal wall, stimulation electrodes, and copper wire. Right: An artistic representation of the same 
set up.  
 The MLT1030/D force transducer has five stainless steel blades, four of which are 
removable in order to adjust the force range and accuracy of the sensor. For preliminary testing, 
the force transducer will be attached to the abdominal wall via a suture thread, which is similar to 
the method in a study by Brown et al [44]. The following table lists the force ranges and 
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accuracies of the transducer. This specific force sensor was chosen because it was able read force 
ranges that are similar to the study by Brown et al, where they isolated and stimulated a rat 
abdominal wall to measure its force of contraction.  
 
 
Table 3.1 The Range and Accuracies of the MLT1030/D 
Number of Blades Range Accuracy 
1 Blade 100mg – 15g  25mg 
2 Blades 6g – 300g  100mg 
3 Blades 10g – 500g  175mg 
4 Blades 15g – 750g  250mg 
5 Blades 20g – 2000g  350mg 
 
 The tissue holder platform has three slits that allow for the clamps to be adjustable. In 
addition, it allows for the perfusate to collect in a reservoir below the tissue as it drains out from 
the edges of the tissue during perfusion. The perfusate collects in the reservoir and is able to be 
pumped out of the reservoir. A close up of the tissue holder platform and the drainage reservoir 
can be seen in Figure 3.6.  
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Figure 3.6 Close Ups of the Tissue Holder Platform and Drainage Perfusate Reservoir. As the perfusate 
drains out of the edges of the graft, it will fall down the slits in the platform (Top) into the perfusate drainage 
reservoir (Bottom) for collection and pumping back into the main reservoir.  
 Once the bioreactor is assembled, there are four removable panels that allow access into 
the bioreactor. This easily allows for the placement of the tissue into the bioreactor and the 
attachment of the tubing and any other necessary connections. With the panels removed, it 
allows for access through the front, top, and back of the bioreactor, which is necessary since it 





Figure 3.7 The Four Removable Sliding Panels. Top: The four sliding panels are highlighted to show their 
position in the bioreactor. Bottom Left: The closed bioreactor with panels in place. Bottom Right: The open 
bioreactor with all sliding panels removed.  
3.2 Bioreactor Prototype 
 As of the time of the writing of this thesis, the finalized bioreactor has not been 
machined. It will be sent to John Hopkins University’s Whiting School of Engineering’s 
Machine Shop for construction. In the meantime, a 3D printed prototype of the bioreactor has 
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been constructed using the Grayson LabCOTE’s LulzBot Taz 5 3D printer and white 
Acrylonitrile Butadiene Styrene (ABS). It will be used for initial testing and data collection. 
Below are several images of the 3D printed bioreactor that was used for testing.  
 
Figure 3.8 Side Views of Closed 3D Printed Bioreactor Prototype 
 
Figure 3.9 Close Up of Perfusion Ports and Electrode Tab 
 The ports were changed from the original design and tubing was pushed through the 
walls instead of using barbed plastic tube fittings. This was changed due a leaking problem. The 
metal L bracket is used to connect the electrical stimulation system to the bioreactor via an 
alligator clip.  
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Figure 3.10 Front View of Opened 3D Printed Bioreactor Prototype. The inner components can be seen: the 
fanned out force sensor, perfusion tubing and needle, electrode wires, and clamps. 
 























Figure 3.12 Close Up of Perfusate Drainage Well. The holder platform has been removed to allow 
visualization of the lower well.  
3.3 Sterile Assembly 
 In order to ensure sterility of the bioreactor, it has been designed to be able to break down 
into multiple pieces for sterilization. An exploded view of the bioreactor and its parts can be seen 
in Figure 3.13. After the individual pieces are cleaned and sterilized with 70% ethylene oxide, 
the bioreactor parts are assembled together and sealed within a sterile environment such as a 
clean room. Afterwards, the bioreactor is transported to the surgery site and opened to allow the 
installation of the graft. Even though the surgical field is considered sterile, there is a minimal 
chance of contamination during the process of the graft installation inside the bioreactor. 




















CHAPTER 4: PERFUSION TESTS 
4.1 Flow Through System 
 In order to maintain the graft at a functioning state outside of the body, an adequate 
supply of oxygen and glucose is needed to be delivered throughout the graft. Thus a peristaltic 
pump will be used to drive the perfusate throughout the system while the other components of 
the flow circuit will condition the media as well as monitor various components of the perfusate. 
In this iteration of the flow circuit, a heater and bubble trap were not included. A hot plate will 
be used to heat the entire perfusate instead. The needle used to perfuse the tissue is a 25-gauge 
needle with a 1-inch tip by Nordson EFD.  
 
Figure 4.1 Flow Circuit Diagram. Perfusion starts with the peristaltic pump pulling perfusate from the 
main reservoir and driving it through the series of inline sensors and into the bioreactor with the 
abdominal wall. From there, the perfusate drains out of the edges of the graft and into the drainage well. 
From there, the perfusate is pulled into the second series of inline sensors and back into the main 
perfusate reservoir 
 4.1.1 Components of Flow Circuit 
 This system uses 1/8-inch inner diameter PharMed BPT biocompatible tubing to connect 
the individual parts of the flow system. The Ismatec IP8 is an 8 channel peristaltic pump whose 
speed can be controlled. It also has an analog interface on its back to allow for electronic control 
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of the pump. This allows for the pump to be automated. A custom MATLAB graphic user 
interface and script to control that interface were created. It allows for the user to control the on 
and off cycle of the pump for intermittent perfusion is desired. The code for the interface and 
script can be found in the appendix.  
 
Figure 4.2 The Ismatec IP 8 Peristaltic Pump 
  
  
Figure 4.3 Main Perfusate Reservoir with a Mix of Evans Blue Dye and Saline. It was machined from a 
250mL glass media bottle with three holes drilled in the cap. One for pump to pull perfusate out, one for 
pumping perfusate back in, and one for passive oxygen diffusion into the perfusate.  
 Originally, an oxygenator was to be added into the perfusion circuit. However, 
calculations were performed to determine the amount of oxygen needed by the rat abdominal 
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wall and it was found that passive oxygen diffusion provided an adequate amount of oxygen. 
Thus an additional opening to the reservoir was added. A tube with a bacterial filter would be 
inserted into that hole. This allows for passive oxygen diffusion while maintaining the sterility of 
the perfusate. Below are calculations for passive oxygen diffusion and estimating the rate of 
oxygen consumption for the rat abdominal wall.  
Rate of Oxygen Consumption: 600 uL/hr/g = 10 uL/min/g [45] 
Rate of Oxygen Consumption Per Gram: 10 uL/min/g * (1mol/22.4L) = 4.46E-7 mol/min/g 
Average Weight of Rat Abdominal Wall = 5g 
Rate of Oxygen Consumption = 2.23E-6 mol/min 
 
PO2: atmospheric partial pressure of O2: 0.21 atm 
H: Henry’s constant: 769.23 [(L * atm) / mol] 
CO2: concentration of O2 in perfusate 
 
PO2 = H * CO2 
CO2 = PO2 / H = 0.21 atm / (769.23 (L * atm)/mol) 
CO2 = 2.73E-4 mol/L 
Currently use 80 mL of perfusate at a time: 
O2 = CO2 * L = 2.73E-4 mol/L * 0.08L = 2.18E-5 mol of O2  
 
 To measure the composition of the perfusate, various inline sensors will be incorporated 
into the perfusion loop. Included are one pressure transducer, two oxygen probes, 2 
thermocouples, and 2 pH probes. The ion sensors are fitted with a flow through fitting as seen in 
Figure 4.5. The sensors are all connected to the 16/35 PowerLab by ADInstruments, which is a 
data acquisition unit that is capable of reading up to 16 inputs at once. The LabChart program is 
used to read the data from the PowerLab. 
 
Figure 4.4 An Ion Sensor with a Flow Through Fitting 
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Figure 4.5 The PowerLab with Two Accompanying Bridge Amplifiers 
  
 4.1.2 Calibration of the Sensors 
 Due to the nature of the bioreactor and the perfusate drainage method, the pressure sensor 
is only able to be used at the inlet while the temperature, oxygen, and pH sensors can be used to 
analyze the perfusate as it enters and leaves the bioreactor.  
 All of the sensors were connected inline and different solutions were pumped through 
them in order to calibrate the sensors and ensure the that the readings were accurate. This can be 
seen in a screenshot of the LabChart program in Figure 4.7. All of the data can be exported into 
various file formats for further data processing. Initially, the circuit was primed with standard 
cold tap water. This can be seen with the vertical dotted line labeled prime. At time zero, the 
source of the pump inlet was switched to a beaker full of hot tap water. The temperature readings 
of the temperature sensors, T1 and T2, can be seen rising up to almost 35C. At 1:00, the source 
was switched to a beaker full of cold tap water and the temperature readings can be seen 
dropping down to about 21C. At 2:00, the source was switched to a 0% oxygen solution (made 
by adding 12g of sodium metabisulfite to 500mL of water). At about 2:30, the oxygen readings 
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can be seen dropping down 0%. The pH readings also drop down to about 2 because the 0% 
oxygen solution is acidic. At 3:00 and 4:30, the source was switched to a beaker full of a 4.01 
and 7.01 pH buffered solution respectively. About 30 seconds after those respective time points, 
the pH readings can be seen rising to 4 and 7. The force sensor was connected but was not used 
during this test. The pressure sensor was also attached but a perfusion needle was not attached to 
the end of the tubing so pressure remained around 15mmHg. The pump was operated at 100% of 
its max speed during the majority of this test. The pump ran at 5% of its max speed during brief 
periods of switching the reservoir and between 4:00-4:30.  
 
Figure 4.6 Flow Through Sensor Graph Readings from LabChart. The vertical dashed lines represent when 
the perfusate was changed. At first, the system was primed with standard tap water (PRIME). At time zero 
(0:00), the source was changed to hot tap water. At 1:00, the source was changed to cold tap water. At 2:00, 
the source was changed to a 0% oxygen solution. At 3:00 and 4:30, the source was changed to a 4.01 pH 
buffer solution and 7.01 pH buffer solution respectively.  
4.2 Experimental Set Up and Methods 
 The bioreactor prototype was tested with an abdominal wall as a proof of concept. The 
abdominal wall was harvested according to the steps in Section 2.2 with the exception that the 
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vessels were not cut until the bioreactor system was set up. Thus, the abdominal wall had its 
edges cauterized but was not cut off from the blood supply for about 2 hours. Once the bioreactor 
was set up, the vessels of the graft were cut and the 25-Gauge perfusion needle was inserted into 
the artery. The blood was then flushed out of the graft with heparinized saline as described in 
Section 2.2. Next, the tissue was clamped within the bioreactor and a suture wire was threaded 
through the tissue and tied to the end of the force sensor. Figure 4.7 shows how the tissue was 
installed within the bioreactor. The rest of the perfusion system was connected to the tissue and 
heparinized saline was pumped throughout the system and graft at 0.5 mL/s to allow for an 
electrical stimulation test as described in Section 5.3.2. The complete perfusion system can be 
seen in Figure 4.8.  
 
Figure 4.7 How the Tissue is Attached to the Force Sensor 
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Figure 4.8 The Perfusion System Connected to the Bioreactor Prototype. On the right is the bioreactor 
prototype with force sensor protruding from its top. To its left are the inline sensors, the peristaltic pump, 
and the main perfusate reservoir.  
 After the stimulation test was completed, Evans Blue Dye was perfused throughout the 
system as a proof of concept of the perfusion system. The blue dye allows for the visualization of 
the perfusate as it travels through the graft. During all of this, the flow through sensor system 
was connected to the bioreactor in order to take force, pressure, temperature, oxygen, and pH 
readings.  
4.3 Results 
 Heparinized saline was perfused through the abdominal wall for one hour at a flow rate 
of 0.5 mL/s. Afterwards, Evans Blue Dye was perfused through and the tissue was rapidly 
colored by the tissue. Images of the tissue progressively becoming more dyed can be seen in 









Figure 4.9 Perfusion of the Abdominal Wall with Evans Blue Dye at Three Different Time Points 
 Below are several graphs of the sensor readings throughout the perfusion period. 
 
Figure 4.10 Pressure Readings 
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Figure 4.11 Temperature Readings 
 
Figure 4.12 Percent Oxygen Readings 
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Figure 4.13 Percent pH Readings 
 
Figure 4.14 Air Bubbles in the Outflow Tubing 
 
Figure 4.15 Perfusate Reservoir with Mixed Saline. Normally saline is clear but the saline is colored pink 
after haven been driven through the abdominal wall.  
4.4 Discussion 
 The goal of this section was to develop a perfusion system that is capable of delivering 
perfusate throughout the tissue while conditioning the perfusate. As the perfusate is driven 
though the vessels of the abdominal wall, oxygen and other nutrients are delivered to enable 
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aerobic metabolism. Figure 4.16 shows the perfusate reservoir with saline, which is normally 
clear. The pink coloration shows how the perfusion circuit is able to operate within a continuous 
loop: perfusate is pulled from the reservoir and pumped throughout the bioreactor and tissue until 
it leaks out and is pumped back into the reservoir. 
 As seen in Figure 4.9, the pump is able to connect into the bioreactor to perfuse the 
abdominal wall. As Evans Blue Dye is pumped throughout the circuit, the abdominal wall is 
colored blue. Figure 4.3 shows a picture of the main reservoir that is full of saline. The blue 
coloration is due to the blue dye that was collected as it leaked out of the tissue.  
 Figures 4.11-4.14 show the pressure, temperature, oxygen, and pH readings of the 
perfusate during the perfusion. The pressure graph shows an initially high pressure reading of 
about 90 mmHg before dropping down to about 10 mmHg while the temperature graph shows 
that the temperature of the perfusate as it enters and leaves the bioreactor is about 22C, which is 
expected as the hot plate was not used. The oxygen graph shows a higher concentration of 
oxygen in the perfusate as it enters the bioreactor (about 17%) compared to the perfusate as it 
leaves the bioreactor (about 8%). This is somewhat as expected because the abdominal wall 
should use some oxygen for metabolism. However, the 9% difference is significantly greater 
than expected. The pH of the perfusate readings indicate that the system stabilizes around a pH 
of 6 as it enters the bioreactor and around 2 as it leaves. This is also somewhat expected since the 
abdominal wall is expected to be undergoing ischemia, but there is a drastic difference in the pH 
levels. In addition to the strange values, there are many fluctuations in the sensors, which is 
related to their sensitivity. Thus, the sensors should be placed in a secure location during their 
readings in order to prevent the noise. As expected, there are air bubbles in the outflow tubing 
returning to the main reservoir, as seen in Figure 4.15, which would affect the outflow readings. 
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This is due to the nature of the bioreactor and how the perfusate drains into a pool before being 
pumped back into the main reservoir. A bubble trap should be placed between the outflow port 
of the bioreactor and the sensors to fix this problem in the future. In addition, all of the data has 
been smoothed using a moving average function. 
 Overall, the bioreactor allows for the perfusion of the abdominal wall while the inline 
sensors are able to measure the components of the perfusate. However, the readings from the 
sensors are unstable and further work needs to be done to stabilize them.   
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CHAPTER 5: ELECTRICAL STIMULATION 
5.1 Electrical Stimulation Background 
 Several studies have shown that electrical stimulation can help with wound healing, 
muscle growth, nerve regeneration, and as well as reducing muscle atrophy after injury [46-49]. 
By combining electrical stimulation of the graft along with normothermic perfusion, we hope to 
both enhance and extend the preservation time of the rat abdominal wall VCA model.  
 Monophasic stimulation only has one polarity, such as using direct current, and results in 
a net ion flow in tissue, which can cause tissue damage and corrosion [50]. Those disadvantages 
can be avoided with Biphasic stimulation with alternating current.  
5.2 Circuit Design and Theory 
 The circuit used for electrical stimulation is an H-Bridge Circuit. It allows for the voltage 
applied across a load to reverse its polarity. In other words, the H-Bridge Circuit converts direct 
current to alternating current, which allows for biphasic stimulation of tissue. An H-Bridge 
circuit is essentially a series of four switches or gates that open and close to adjust the polarity of 
the voltage that is applied across a load. This H-Bridge Circuit uses two P-Channel MOSFETs 
and two N-Channel MOSFETS as the four switches.  
 A MOSFET (metal-oxide-semiconductor field-effect transistor) is a type of transistor that 
changes its conductance between its Source and Drain terminals based on the voltage applied at 
one of its terminals, the Gate. P-Channel MOSFETs are open by default and only close when a 
positive voltage is applied at its gate. N-Channel MOSFETs are closed by default and only open 
when a positive voltage is applied at its gate. A schematic for the P-Channel and N-Channel 
MOSFETs can be seen in Figure 5.1.  
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Figure 5.1 Schematics of P-Channel and N-Channel MOSFETs 
 The four MOSFETs are controlled by two inputs voltages, Inputs A and B, which are 
determined by the Arduino Microcontroller output pins. Between the Inputs and the MOSFETs 
are two NPN transistors and two current limiting resistors. The transistors protect the output pins 
from the high voltage running through the circuit by only allowing current to flow from the 
output pin into the rest of the circuit instead of vice versa. The current limiting resistors simply 
limit the amount of current that comes from the output pins of the Arduino Microcontroller to 
protect the transistors.  Throughout the rest of the circuit, there are several gate bleeding 
resistors, which allow the MOSFETs to drain properly and thus function properly. Figure 5.2 
shows a schematic of the H-Bridge circuit and all of its components. The load in the center of the 
circuit is where the polarity of the voltage switches and thus that is where the tissue will be 
connected to the circuit. In other words, the tissue that is to be stimulated is the load. 
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Figure 5.2 H-Bridge Circuit Schematic. This includes the power source (Vcc), the 4 MOSFETs that act as 
gates, the load that the current passes through for stimulation, and the two inputs A and B.  
 The orientation of the four MOSFETs changes based on the voltages from the two Inputs. 
Figure 5.4 shows the type of waveform produced by flipping the inputs, a biphasic or alternating 
waveform as measured by an oscilloscope. By having the microcontroller turn on and off the 
Inputs at an appropriate rate, any desired frequency for stimulation can be produced.  
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Figure 5.3 The Two Possible Orientations of the H-Bridge Circuit. In the top image, Input A is turned on 
while Input B is off. This allows for the top right P Channel MOSFET and the bottom left N Channel 
MOSFET to open, allowing the current to flow from the right to left across the load. The bottom image shows 
the circuit’s activity when Input B is turned on while Input A is off. In this case, the orientation of the open 
gates allows for the current to flow from left to right across the load.  
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Figure 5.4 The Output Waveform from the H-Bridge Circuit Measured by an Oscilloscope.  
5.3 Experimental Set Up and Methods 
 Two separate sets of experiments were done with the electrical stimulation system. The 
first was an isolated test of the electrical stimulation system on a harvested rat abdominal wall as 
a proof of concept. The second was a test of the electrical stimulation system in conjunction with 
the complete bioreactor system and perfusion test from Chapter 4.   
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Figure 5.5 Electrical Stimulation Set Up. 1) A power supply to provide the stimulus, 2) an H-Bridge Circuit to 
direct the stimulus, 3) an Arduino Microcontroller to control the gates of the H-Bridge Circuit, 4) a laptop 
that powers the Arduino Microcontroller and uploads code into the microcontroller, and 5) a pair of 
stimulation electrodes.  
 5.3.1 Electrical Stimulation Experiment 1: Proof of Concept 
 The rat abdominal wall was harvested according to the steps from Chapter 2 with the 
exception that the vessels were not dissected. This was done in order to speed up the surgery 
because the experiment did not involve perfusion so perfusion and preservation of the blood 
vessels were not necessary. The surgery was completed at 10:54 A.M. and the electrical 
stimulation tests began at 11:04 A.M. Before stimulation, the tissue was placed in a small petri 
dish and coated with a thin layer of Signa Gel Electrode Gel. Afterwards, two tin coated 22-
gauge copper wires were connected between the H-Bridge circuit’s output and the gel. An 
iPhone 6S Plus was mounted above the tissue in order to record the stimulation results since the 
force sensor was not available for use at the time. The tissue was then stimulated with 7 V at 70 







MATLAB in order to measure the percent of contraction of the tissue upon stimulation. The 
script analyzed each frame of the video by cropping everything that was not within the area of 
interest (the tissue itself), converting the frame to gray scale, thresholding the image, and then 
measuring the white area or the area of the tissue. After measuring the area of interest for each 
frame, the script would look for the large and lowest areas of tissue calculated. Those would 
represent the tissue at an unstimulated and stimulated state. The script would then use two 
numbers to calculate the percentage of area contraction with the following equation:  
                                  
                   
        
     
 5.3.2 Electrical Stimulation Experiment 2: Within the Bioreactor  
 The abdominal wall used for this experiment is the same wall used in Section 4.2. The 
abdominal wall was removed from the rat and its edges were cauterized but the vessels were still 
connected as the bioreactor system required time to set up. This took about 2 hours. Once the 
bioreactor was ready for the abdominal wall, the vessels were cut and the perfusion needle was 
then inserted into the vessels to flush out the blood with heparinized saline. Next, it was clamped 
down within the bioreactor and connected to the force sensor via a suture thread. The electrode 
gel was then applied to the top surface of the abdominal wall and the electrode wires were placed 
to contact the gel. Heparinized saline was then pumped throughout the tissue at 0.5 mL/min 
throughout the experiment. 7V of stimulation were applied at 70 Hz to the tissue in 300 ms pulse 
trains every 4.7 seconds and the force of contraction was measured. The same phone was used to 
record a video of the tissue contraction.  
 52 
5.4 Results 
 5.4.1 Electrical Stimulation Experiment 1 Results 
 Figure 5.6 shows two frames taken from the recorded video in Section 5.3.1. The left 
image shows the tissue when it is unstimulated while the right image shows the tissue 
contracting due to stimulation. Figure 5.7 shows the different stages of the video processing as 
described in Section 5.3.1. According to the script, the electrical stimulation caused a 14.5% 
change in area upon stimulation.  
 
Figure 5.6 Experiment 1: Frames of the Tissue when Unstimulated (Left) and Stimulated (Right) 
 
Figure 5.7 Different Stages of the Video Analyzing Process. 1
st
: Entire Frame, 2
nd





: Threshold Images 
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 5.4.2 Electrical Stimulation Experiment 2 Results  
 Figure 5.8 shows two frames from a video recording of the tissue being stimulated 
within the bioreactor. Since there was very little contraction, an arrow and line were placed at the 
same position in both frames to help visualize the contraction. On the right image, the tissue is 
contracted from stimulation and there is a greater distance between the line and the tissue 
compared to the left image where the tissue is not stimulated. In addition, the pattern of light 
reflection due to the electrode gel is different in both images, which suggests that the tissue 
contracted and changed shape.  
 
Figure 5.8 Experiment 2: Frames of the Tissue when Unstimulated (Left) and Stimulated (Right) 
 Figure 5.9 shows the measurements taken by the force sensor. Unfortunately, since the 
contraction was very small and limited to the top left corner, the force sensor was unable to read 
any force changes due to its site of attachment to the tissue.  
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Figure 5.9 Experiment 2: Force Measurement Readings 
5.5 Discussion 
 The goal of this section was to develop a system that is capable of stimulating the rat 
abdominal walls to contract. At first, the H-Bridge circuit was designed and implemented in 
order to be able to convert a direct current into alternating current of any specific frequency. That 
alternating current is then used to provide biphasic electrical stimulation to the rat abdominal 
wall. As mentioned before, biphasic stimulation is preferred over monophasic stimulation due to 
biphasic stimulation being able to maintain the ion concentration in the tissue thus avoiding 
tissue damage.  
 Experiment 1 served as a proof of concept that the electrical stimulation system could be 
used to stimulate the rat abdominal wall and elicit a contraction from it. Since the force sensor 
was not available to use for this, a video was used to record the stimulation and a MATLAB 
script was used analyze the video frames. It showed that the electrical stimulation system was 
able to stimulate the rat abdominal wall and cause a contraction. 
 Experiment 2 served as a test to determine whether or not the electrical stimulation 
system could be incorporated into the bioreactor prototype. Even though the force sensors were 
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unable to sense any forces caused by the tissue’s contractions, this experiment should still be 
considered a success because as seen in Figure 5.8, the tissue is still able to contract, even 
though it is a very small amount. This is probably due to the fact that the tissue was not perfused 
and stimulated immediately after the harvest surgery until about two hours later. If the bioreactor 
was set up properly and the tissue was stimulated almost immediately after harvesting, as seen in 
Experiment 1, the tissue would have contracted enough for the force sensor to read it.  
 Overall, these two experiments are useful because it shows they help define a time limit 
on how long the abdominal wall is able to sit after its edges are cauterized even if the vessels are 
connected as well as give information to design a better connector between the abdominal wall 
and force sensor. Instead of anchoring the force sensor to the tissue with a thread at a single 
point, a scaffold can be designed to attach to the tissue at multiple points with sutures. 
Afterwards, that scaffold can be attached to the force sensor to allow it to sense any force 




CHAPTER 6: CONCLUSIONS 
 This project focused on developing a bioreactor for normothermic perfusion of rat 
abdominal wall VCA. The rat abdominal wall was used as the VCA model for this project 
because abdominal wall transplants are the second most common type of VCA. Even though 
there are commercialized perfusion systems for organ preservation, there are no specific systems 
for VCA.  
 By combining normothermic perfusion and electrical stimulation, the preservation times 
of VCA can hopefully be extended from the current gold standards of 4-6 hours up to 12 hours 
and eventually 72 hours. In addition, various inline sensors are incorporated to help monitor the 
health and status of the graft. Once the nitric oxide, reactive oxygen species, glucose, and lactate 
inline sensors have been developed by our collaborators, they can be easily incorporated into the 
bioreactor system.  
 The bioreactor was designed to accommodate the abdominal wall VCA, the perfusion 
system, and the electrical stimulation system. A prototype was 3D printed with ABS plastic and 
used for testing. The prototype was able to store the abdominal wall and simultaneously allows 
for both perfusion and electrical stimulation of the abdominal wall.  
 Throughout the tests, valuable data and insight was obtained in order to better inform the 
design for the next iteration of the bioreactor. For example, a different method of clamping the 
abdominal wall to the bioreactor and force sensor should be designed since the current method 
only anchors the force sensor to a single point on the tissue and is unreliable. In addition, future 
testing and calibration should be done with the sensor to increase their reliability.  
 But overall, this bioreactor was able to both perfuse and electrically stimulate the rat 
abdominal wall. This allows for the study of different methods to extend the preservation time of 
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this VCA model, such as changing the electrical stimulation regime or adding different 
components to the perfusate. Eventually, once the abdominal wall VCA’s preservation times 
have been extended to a satisfactory time, this bioreactor can be easily modified to accommodate 
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List of Materials for Bioreactor 
 1x Base 
 1x Left Wall 
 1x Right Wall 
 1x Back Wall  
 1x Top Cover 
 1x Perfusate Drainage Reservoir 
 1x Tissue Clamp Platform 
 2x Back Panels 
 1x Front Panel 
 1x Top Panel 
 2x Clamps 
 1x Ismatec IP8 8 Channel Peristaltic Pump  
 1x 16/35 PowerLab 
 2x FE221 Bridge Amplifier 
 1x MLT1030/D Force Transducer 
 1x MLT1199 Pressure Transducer 
 2x 8-730 Flow-Through Oxygen Probes 
 2x O2-ADPT100-BNC O2 Adaptor 
 2x MLT1402 T-Type Thermocouples 
 2x T-Type Pods 
 2x 8-705 Flow-Through pH Probes 
 2x 8-702 Flow-Through pH Reference Electrodes  
 2x MV-ADPT-BNC Millivolt Adaptors  
 2x Electrode Tab 
 2x Electrode Screw 
 26x 0/80 x 3/8 Phillips Flat Machine Screws 
 10x Female Luer Locks 
 10x Male Luer Locks 
 1x Glass Media Bottle 
 1x TP3005T Power Supply 
 1x Arduino Uno Microcontroller 
 1x Circuit Prototyping Board 
 2x FQP27P06 P-Channel MOSFETs 
 2x FQP30N06L N-Channel MOSFETs 
 2x BC33716BU NPN Transistors 
 4x 20k Resistors 
 4x 1.5k Resistors 
 1x Electronix Express Solid Wire Kit 
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Arduino Code: Electrical Stimulation  
long double frequency = 70.0; //Hz 
long double x = 1000.0 / (frequency * 2.0); 
//x = half period in ms 
long double period = x * 2.0; 
 
long double num_runs = 300.0 / period; //300 for 300ms 
void setup()  
{ 
  pinMode(13, OUTPUT); 
  pinMode(11, OUTPUT); 
  digitalWrite(11, LOW); 
  digitalWrite(13, LOW); 
} 
 
void loop()  
{ 
  delay(4.7*1000); 
  //300ms Pulse of x frequency 
  for(int i = 1; i <= num_runs; i = i + 1 ) 
  { 
        digitalWrite(11, LOW); 
        digitalWrite(13, HIGH); 
        delayMicroseconds(x*1000); 
        digitalWrite(13, LOW); 
        digitalWrite(11, HIGH); 
        delayMicroseconds(x*1000); 
   } 
  digitalWrite(13, LOW); //Setting everything low again 
  digitalWrite(11, LOW); 
 
 




str1 = 'IMG_74'; 
str3 = '.m4v'; 
  
video = 1; 
  
for i = [23:25] 
    str2 = int2str(i); 
    string = strcat(str1, str2, str3); 
    x = VideoReader(string); 
  
 64 
    frame = 1; 
while hasFrame(x) 
    I1 = readFrame(x); %Get the frame from the video 
    I2 = imcrop(I1,[130 400 750 850]); % xstart ystart xsteps ysteps 
    I3 = rgb2gray(I2); 
    %I4 = imbinarize(I3); 
     
  I4 = I3; 
for r = 1:851 
    for c = 1:751 
        if I4(r,c) >= 120 
            I4(r,c) = 255; 
        else  
            I4(r,c) = 0; 
        end 
    end 
end 
  










    frame = frame+1 
end 
  
video = video + 1 
end 
  
num = 1; 
for i = 1:3 
    stuff(i, 1) = max(total(:,i)); 
    temp = total(:,i); 
    stuff(i, 2) = min(temp(temp>0)); 
     







MATLAB Code & GUI: Automation of the Pump 
 
function varargout = Pump_GUI(varargin) 
% PUMP_GUI MATLAB code for Pump_GUI.fig 
%      PUMP_GUI, by itself, creates a new PUMP_GUI or raises the existing 
%      singleton*. 
% 
%      H = PUMP_GUI returns the handle to a new PUMP_GUI or the handle to 
%      the existing singleton*. 
% 
%      PUMP_GUI('CALLBACK',hObject,eventData,handles,...) calls the local 
%      function named CALLBACK in PUMP_GUI.M with the given input arguments. 
% 
%      PUMP_GUI('Property','Value',...) creates a new PUMP_GUI or raises the 
%      existing singleton*.  Starting from the left, property value pairs are 
%      applied to the GUI before Pump_GUI_OpeningFcn gets called.  An 
%      unrecognized property name or invalid value makes property application 
%      stop.  All inputs are passed to Pump_GUI_OpeningFcn via varargin. 
% 
%      *See GUI Options on GUIDE's Tools menu.  Choose "GUI allows only one 
%      instance to run (singleton)". 
% 
% See also: GUIDE, GUIDATA, GUIHANDLES 
  
% Edit the above text to modify the response to help Pump_GUI 
  
% Last Modified by GUIDE v2.5 29-Nov-2017 15:23:21 
  
% Begin initialization code - DO NOT EDIT 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @Pump_GUI_OpeningFcn, ... 
                   'gui_OutputFcn',  @Pump_GUI_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 
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    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 
% End initialization code - DO NOT EDIT 
  
% --- Executes just before Pump_GUI is made visible. 
function Pump_GUI_OpeningFcn(hObject, eventdata, handles, varargin) 
% This function has no output args, see OutputFcn. 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% varargin   command line arguments to Pump_GUI (see VARARGIN) 
  
% Choose default command line output for Pump_GUI 
handles.output = hObject; 
  
% Update handles structure 
guidata(hObject, handles); 
  
% UIWAIT makes Pump_GUI wait for user response (see UIRESUME) 
% uiwait(handles.figure1); 
  
%Connecting Matlab to Arduino 
disp('Setting up Arduino Settings... Please wait...'); 





a = arduino('/dev/cu.usbmodem1421','Uno') 
disp('The Arduino is now ready.'); 
  
voltage = get(handles.slider_voltage,'Value'); 
handles.text_voltage.String = [num2str(voltage)]; 
  
handles.push_connect.Visible = 'on'; 
handles.push_forward.Visible = 'off'; 
handles.push_stop.Visible = 'off'; 
  
handles.push_disconnect.Visible = 'off'; 
handles.push_backwards.Visible = 'on'; 
handles.push_run.Visible = 'on'; 
  
global runFlag %0 means pump is stopped 
runFlag = 0; 
%Default Values 
writeDigitalPin(a, 'D2', 1); %Pin2: 1 = Pump, 0 = Remote 
writeDigitalPin(a, 'D4', 1); %Pin4: 1 = Clockwise, 0 = Counterclockwise 
writeDigitalPin(a, 'D3', 1); %Pin3: 1 = Stop, 0 = Run 
writeDigitalPin(a, 'D5', 0);  
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writeDigitalPin(a, 'D13', 0);%Pin 13: 0 = Control speed via panel 
%writePWMVoltage(a, 'D5', 0); 
  
  
% --- Outputs from this function are returned to the command line. 
function varargout = Pump_GUI_OutputFcn(hObject, eventdata, handles)  
% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Get default command line output from handles structure 
varargout{1} = handles.output; 
  
  
% --- Executes on button press in push_run. 
function push_run_Callback(hObject, eventdata, handles) 
% hObject    handle to push_run (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 





handles.push_run.Visible = 'off'; 
handles.push_stop.Visible = 'on'; 
onTime = str2num(get(handles.edit_on,'String')) 
offTime = str2num(get(handles.edit_off,'String')) 
  
runFlag = 1; 
disp('Pump started'); 
  
while (runFlag == 1) 
    writeDigitalPin(a, 'D3', 0); 
    pause(onTime*60); 
     
    if offTime ~= 0 
        writeDigitalPin(a, 'D3', 1); 
        pause(offTime*60); 
    end 
end  
  
% --- Executes on button press in push_stop. 
function push_stop_Callback(hObject, eventdata, handles) 
% hObject    handle to push_stop (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
global a 
global runFlag 
handles.push_run.Visible = 'on'; 
handles.push_stop.Visible = 'off'; 
writeDigitalPin(a, 'D3', 1); 




% --- Executes on button press in push_forward. 
function push_forward_Callback(hObject, eventdata, handles) 
% hObject    handle to push_forward (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
global a 
handles.push_forward.Visible = 'off'; 
handles.push_backwards.Visible = 'on'; 
writeDigitalPin(a, 'D4', 1); 
disp('Pump set to Forward'); 
  
% --- Executes on button press in push_backwards. 
function push_backwards_Callback(hObject, eventdata, handles) 
% hObject    handle to push_backwards (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
global a 
handles.push_forward.Visible = 'on'; 
handles.push_backwards.Visible = 'off'; 
writeDigitalPin(a, 'D4', 0); 
disp('Pump set to Backwards'); 
  
% --- Executes on button press in push_connect. 
function push_connect_Callback(hObject, eventdata, handles) 
% hObject    handle to push_connect (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
global a 
handles.push_disconnect.Visible = 'on'; 
handles.push_connect.Visible = 'off'; 
writeDigitalPin(a, 'D2', 0); 
disp('Remote control is on'); 
  
  
% --- Executes on button press in push_disconnect. 
function push_disconnect_Callback(hObject, eventdata, handles) 
% hObject    handle to push_disconnect (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
global a 
handles.push_disconnect.Visible = 'off'; 
handles.push_connect.Visible = 'on'; 
writeDigitalPin(a, 'D2', 1); 
disp('Remote control is off'); 
  
  
% --- Executes on slider movement. 
function slider_voltage_Callback(hObject, eventdata, handles) 
% hObject    handle to slider_voltage (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of 
 69 
slider 
voltage = get(handles.slider_voltage,'Value') 




writePWMVoltage(a, 'D5', voltage); 
  
% --- Executes during object creation, after setting all properties. 
function slider_voltage_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to slider_voltage (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 





function edit_off_Callback(hObject, eventdata, handles) 
% hObject    handle to edit_off (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of edit_off as text 




% --- Executes during object creation, after setting all properties. 
function edit_off_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit_off (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 





function edit_on_Callback(hObject, eventdata, handles) 
% hObject    handle to edit_on (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of edit_on as text 





% --- Executes during object creation, after setting all properties. 
function edit_on_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit_on (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
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